Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 30, 2020 17:20 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology Announces Start of New CEO and New Employment Inducement Grants

SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. today announced that Anirvan Ghosh, Ph.D., has officially joined the company as Chief Executive Officer. As...
March 11, 2020 16:05 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results

SOUTH SAN FRANCISCO, Calif., March 11, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing,...
March 03, 2020 16:05 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2019 Financial Results

SAN FRANCISCO, March 03, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
March 02, 2020 16:30 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology Appoints Anirvan Ghosh, Ph.D. as Chief Executive Officer

– Renowned Scientist and Drug Developer Joins UNITY’s Mission to Extend Healthspan – – Succeeds Keith Leonard Who Will Continue as Chairman – SAN FRANCISCO, March 02, 2020 (GLOBE NEWSWIRE) --...
February 25, 2020 06:00 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology Provides Pipeline and Business Updates

– Phase 2 study of UBX0101 in patients with osteoarthritis has completed enrollment – – Topline 12- and 24-week results now expected in 2H 2020 – – First patient dosed in phase 1b study to explore...
February 24, 2020 16:05 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. to Participate in the Cowen and Company 40th Annual Health Care Conference

SAN FRANCISCO, Feb. 24, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
November 06, 2019 16:05 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. Reports Third Quarter 2019 Financial Results and Business Updates

SAN FRANCISCO, Nov. 06, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
October 31, 2019 08:00 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. Announces First Patient Dosed in Phase 2 Study of UBX0101 in Osteoarthritis of the Knee

SAN FRANCISCO, Oct. 31, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today...
October 24, 2019 08:00 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. Announces Upcoming Scientific Presentations at ACR 2019 Annual Meeting

SAN FRANCISCO, Oct. 24, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
October 23, 2019 08:00 ET | Source: Unity Biotechnology, Inc.

Unity Biotechnology, Inc. to Announce Third Quarter 2019 Financial Results

SAN FRANCISCO, Oct. 23, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...